Conditions: Vitreomacular Adhesion
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 326
Healthy volunteers: no

Brief summary:
The objective of this trial is to evaluate the safety and efficacy of intravitreal microplasmin 125µg dose in subjects wiht focal vitreomacular adhesion.

Detailed description:

Arms:
arm 1: 125µg intravitreal injection of ocriplasmin arm 2: placebo intravitreal injection

Interventions: intervention 1: 125 µg Ocriplasmin intervention 2: Placebo
Intervention descriptions: intervention 1: 125µg ocriplasmin intravitreal injection intervention 2: Placebo intravitreal injection

Protocol document: